Figure 6

Pro-inflammatory cytokines favor EIIIApos over EIIIBpos splicing in primary rat astrocytes. (a) Schematic representation of astrocyte treatment and analysis. Primary rat grey matter (gm) and white matter (wm) astrocytes were pre-incubated for 24 hours with a mixture of IFNγ (500 units/mL), IL1β (10 ng/mL) and TNFα (10 ng/mL), and left untreated or treated with Poly(I:C) (50 μg/mL) for 24 hours. (b–d) Western blot analysis of EIIIApos-fibronectin and total fibronectin in total cell lysates. Representative blots of 4 independent experiments are shown in (b), quantification of EIIIApos-fibronectin of total fibronectin in (c) and total fibronectin in (d). Actin serves as a loading control. (e–h) RT-PCR analysis of EIIIApos-, EIIIAneg-, EIIIBpos- and EIIIBneg-Fn mRNA. Representative agarose gels of 4–5 independent experiments are shown in e, quantification of EIIIApos/total Fn, EIIIBpos/total Fn, and EIIIApos/EIIIBpos-Fn mRNA ratios in (f,g,h) respectively. Note that EIIIBpos-Fn mRNA, but not EIIIApos-Fn mRNA levels are decreased in cytokine pre-treated astrocytes (wm + cytokines p = 0.043; wm + cytokines + Poly(I:C) p = 0.031; gm + cytokines p = 0.003; gm + cytokines + Poly(I:C) p = 0.094, ns), resulting in an enhanced EIIIApos/EIIIBpos-Fn mRNA ratio (wm + cytokines p = 0.104, ns; wm + cytokines + Poly(I:C) p = 0.044; gm + cytokines p = 0.075, ns; gm + cytokines + Poly(I:C) p = 0.102, ns). Bars represent mean relative to their respective control astrocytes (ctrl), which was set at 1 for each independent experiment (horizontal line). Error bars show the standard error of the mean. Statistical analyses were performed using a one-sample t-test to test for differences with their respective control astrocytes (*p < 0.05, **p < 0.01).